Trexquant Investment’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,923
Closed -$295K 1661
2021
Q1
$295K Buy
+1,923
New +$261K 0.03% 764
2020
Q4
Sell
-8,191
Closed -$831K 1650
2020
Q3
$831K Buy
8,191
+26
+0.3% +$2.65K 0.05% 481
2020
Q2
$794K Sell
8,165
-2,830
-26% -$263K 0.06% 488
2020
Q1
$913K Buy
10,995
+4,810
+78% +$469K 0.07% 446
2019
Q4
$687K Sell
6,185
-5,862
-49% -$603K 0.04% 465
2019
Q3
$1.2M Buy
+12,047
New +$1.2M 0.1% 248
2019
Q2
Sell
-6,100
Closed -$673K 1257
2019
Q1
$673K Sell
6,100
-1,151
-16% -$120K 0.05% 504
2018
Q4
$667K Buy
+7,251
New +$734K 0.04% 540
2017
Q1
Sell
-8,800
Closed -$485K 1409
2016
Q4
$485K Buy
+8,800
New +$483K 0.08% 453
2016
Q2
Sell
-24,800
Closed -$1.06M 1193
2016
Q1
$1.06M Buy
+24,800
New +$1.05M 0.12% 277

Other funds holding PRAH

Trexquant Investment's PRAH Position: Q2 2021 in Review

Trexquant Investment sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 1,923 shares — an estimated $295K sold.

Trexquant Investment first reported a position in PRAH in Q1 2016 and held it in 10 quarters. The position peaked at $1.2M in Q3 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Trexquant Investment reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Trexquant Investment sold 1,923 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $295K.
  • Trexquant Investment first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 10 quarters.
  • Trexquant Investment's PRA Health Sciences, Inc. position peaked at $1.2M in Q3 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Trexquant Investment's 13F filing for Q2 2021, filed 12 Aug 2021.